NEW YORK, Jan. 4 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced that the Company will be presenting at the Ninth Annual ICR XChange Investor Conference at the St. Regis Monarch Beach Resort & Spa in Dana Point, California, on Thursday, January 11, 2007. Management is currently scheduled to present at 10:35 a.m. PT/1:35 p.m. ET and will meet with institutional investors throughout the day. Listeners may access a live webcast of the presentation by visiting the investor relations portion of the Company's website at http://www.bioaobo.com or by visiting the ICR XChange webcast link at http://www.icr-online.com/xchange/x9/attendee/webcast.htm. For more information on the Ninth Annual ICR XChange, please visit http://www.icrxchange.com or contact ICR at .
In addition, the Company will meet individually with institutional investors at the Brean Murray Carret & Co. One on One Winter Consumer Conference on January 25, 2007 at the Grand Hyatt Hotel in New York City. For more information on the One on One Winter Consumer Conference, please contact your Brean Murray Carret & Co. sales representative.
The Company also announced that it remains comfortable with the fourth quarter 2006 guidance provided in conjunction with its third quarter 2006 earnings release on November 14, 2006. The fourth quarter revenue is expected to be in the range of $37 million to $39 million with diluted earnings per share of at least $0.15.
About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. (AOB) is engaged in the development and production of plant-based pharmaceutical products and plant-based nutraceutical products widely distributed throughout China. For more information, visit http://www.bioaobo.com.
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
SOURCE American Oriental Bioengineering, Inc.